All Stories

  1. Phenotypic and functional patterns of murine bone marrow-derived dendritic cells influenced by in vitro differentiation conditions
  2. Red Alga Porphyridium Supports High‐Yield Production of a Functional Chimeric Hepatitis B Surface Antigen With Strong Cellular and Humoral Immunogenicity
  3. Humanized mouse model reveals the immunogenicity of Hepatitis B Virus vaccine candidates produced in CRISPR/Cas9-edited Nicotiana benthamiana
  4. The red alga Porphyridium as a host for molecular farming: Efficient production of immunologically active hepatitis C virus glycoprotein
  5. Generation of a DSF-Guided Refolded Bacterially Expressed Hemagglutinin Ectodomain of Influenza Virus A/Puerto Rico/8/1934 H1N1 as a Model for Influenza Vaccine Antigens
  6. The “humanized” N‐glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus‐neutralizing antibody response in vaccinated...
  7. Comparison of truncated human angiotensin-converting enzyme 2 (hACE2) expression in pET28a(+) versus pET-SUMO vector and two Escherichia coli strains
  8. Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS116-42 antigen
  9. Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus‐neutralizing activity in vaccinated mice
  10. The Application of Single Use Bioreactors for the Production of a Carotenoids Mix, Mainly Torularhodin
  11. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice
  12. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein
  13. Lettuce-produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination
  14. Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
  15. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant
  16. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania
  17. Model and Kinetic Parameters Identification for Therapeutical Product Obtained According to the GMP Guidelines
  18. The cultivation of Pseudomonas aeruginosa for therapeutic purpose
  19. Regulatory Mechanisms Differ in UMP Kinases from Gram-negative and Gram-positive Bacteria
  20. Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  21. Pycnogenol® efficacy in the treatment of systemic lupus erythematosus patients
  22. Dysregulation of p56 lck Kinase in Patients with Systemic Lupus Erythematosus
  23. p56 lck Activity and Expression in Peripheral Blood Lymphocytes from Patients with Systemic Lupus Erythematosus
  24. DIFFERENTIAL REGULATION OF HUMAN T LYMPHOBLAST FUNCTIONS BY IL-2 AND IL-15
  25. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms
  26. Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
  27. Immunomodulation in Experimental and Clinical Nephrology Using Chimeric Proteins
  28. Tyrosine Phosphorylation in Peripheral Lymphocytes from Patients with Systemic Lupus Erythematosus
  29. Naturally Occurring Anti-Idiotypic Antibodies to Anti-Phosphotyrosine in Systemic Lupus Erythematosus Interact with SRC-Homology 2 Domains
  30. Novel heterogeneity of the leucocyte common antigen (CD45): disulfide-bound heterodimers between CD45 and an 80 kDa polypeptide
  31. Identification of Anti-Idiotypic Antibodies to Anti-Phosphotyrosine Antibodies in Human Sera